ADS-ADEA 2016* , ,
Presentations this author is a contributor to:
Effect of Empagliflozin on Nephropathy in Subgroups by Age: Results from EMPA-REG OUTCOME (#33)
11:45 AM
Michael d'Emden
ADS Clinical Orals - Renal & Foot Complications
Effects of linagliptin on glycemic control and albuminuria in type 2 diabetes - the MARLINA–T2D™ trial (#62)
5:00 PM
Per-Henrik Groop
ADS Clinical Orals - Type 2 Therapies